![](/img/cover-not-exists.png)
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial
Povsic, T. J., Vavalle, J. P., Aberle, L. H., Kasprzak, J. D., Cohen, M. G., Mehran, R., Bode, C., Buller, C. E., Montalescot, G., Cornel, J. H., Rynkiewicz, A., Ring, M. E., Zeymer, U., Natarajan, M.Volume:
34
Language:
english
Journal:
European Heart Journal
DOI:
10.1093/eurheartj/ehs232
Date:
August, 2013
File:
PDF, 432 KB
english, 2013